Tabiiy fanlar

COMPARATIVE EVALUATION OF THE ANTIHYPERTENSIVE ACTIVITY OF SUBSTANCES F-1 AND F-3 IN VIVO AT DIFFERENT DOSES

disability, non-invasive, hypertension, adrenaline hydrochloride, antihypertensive

Authors

  • Муаззам Ш.БАКИЕВА PhD, доцент, Наманганское государственный университет, Наманган, Узбекистан, Uzbekistan

Cardiovascular diseases (CVDs) continue to be the leading cause of mortality and disability worldwide. Approximately 18
million people die annually from cardiovascular diseases, accounting for about 32% of all deaths globally, and around 85% of
these deaths are caused by myocardial infarction and stroke [3]. The study of different doses is important for identifying the
optimal therapeutic window, determining the balance between efficacy and toxicity, and constructing dose–response models.
Such studies may lead to the discovery of new drug candidates, provide justification for mechanisms of action, and serve as a
basis for further preclinical and clinical stages of drug development [7].